Related Experiment Video
Updated: Apr 28, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
16.1K
Inflammation based regulation of cancer cachexia
Jill K Onesti1, Denis C Guttridge2
1Division of Surgical Oncology, The Ohio State University Wexner Medical Center, The Ohio State University College of Medicine, 460 W. 12th Avenue, Columbus, OH 43210, USA ; The Arthur G. James Comprehensive Cancer Center, Columbus, OH 43210, USA.
Biomed Research International
|May 31, 2014
Summary
Cancer cachexia causes severe muscle loss in patients with solid tumors, impacting treatment and quality of life. This review details inflammatory cytokines and procachectic factors driving this wasting syndrome.
Area of Science:
- Oncology
- Immunology
- Physiology
Background:
- Cancer cachexia is a debilitating condition characterized by significant skeletal muscle wasting in solid tumor patients.
- This wasting occurs independently of nutritional intake and negatively impacts surgical outcomes, therapeutic efficacy, and patient quality of life.
Purpose of the Study:
- To review the clinical implications of cancer cachexia.
- To summarize the background of inflammatory cytokines and procachectic factors involved in muscle wasting.
- To elucidate the molecular mechanisms linking tumor-induced immune response to skeletal muscle wasting.
Main Methods:
- Literature review of clinical implications.
- Summary of inflammatory cytokine and procachectic factor origins.
- Description of molecular pathways.
Main Results:
- Identified key procachectic factors including TNF-α, IL-6, IL-1, INF-γ, and PIF.
- Detailed the role of inflammatory cytokines in mediating muscle wasting.
- Elucidated molecular mechanisms connecting tumor presence to skeletal muscle loss.
Conclusions:
- Cancer cachexia is a complex syndrome driven by tumor-associated inflammation.
- Understanding the molecular pathways is crucial for developing therapeutic strategies.
- Targeting procachectic factors and inflammatory cytokines may mitigate skeletal muscle wasting.
Related Concept Videos
01:28Inflammatory Response
12.4K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.4K
01:31The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:31Regulation of the Unfolded Protein Response
2.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K